Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dermcity AB
AB
Active
Org 5594100314
Körsbärsvägen 12
Medical specialists activities · NACE 8622
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 76K
-5% vs 2023
EBITDA margin
64.5%
+23% vs 2023
Equity ratio
66.0%
Financial strength
Net profit 2024
SEK 39K
+22% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 76K
-5%
EBITDA
SEK 49K
+23%
Net profit
SEK 39K
+22%
Total assets
SEK 100K
-18%
Equity
SEK 66K
+16%
Employees
1
—
Company information
Legal name
Dermcity AB
Org number
5594100314
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
6 december 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom specialistläkarvård med inriktning hudsjukdomar
Contact
Address
Körsbärsvägen 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
80
76
Staff expenses
—
—
EBITDA
40
49
Depreciation & amort.
−0
−0
EBIT
40
49
Net financials
—
—
Profit before tax
40
49
Tax
−8
−10
Net profit
32
39
Balance sheet
SEK thousands
Item
2023
2024
Total assets
122
100
Equity
57
66
Long-term debt
0
0
Short-term debt
65
34
Total debt
65
34
Financial ratios
5-year trend
EBITDA margin
64.5%
This company
15.8%
Market median
+308% vs market
2023
2024
Equity ratio
66.0%
This company
38.2%
Market median
+73% vs market
2023
2024
Return on equity
59.1%
This company
18.4%
Market median
+221% vs market
2023
2024
Net profit margin
51.3%
This company
8.1%
Market median
+533% vs market
2023
2024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
2023
2024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KK
Kambiz Kafi
Deputy Board Member
2022
PK
Pegah Kafi
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dermcity AB also hold positions in
0
other companies.
Person
Role here
Other companies
Kambiz Kafi
Deputy Board Member
0 companies
Pegah Kafi
Board of Directors
0 companies